Literature DB >> 16755450

Clinical impact of interstitial pneumonia following surgery for lung cancer.

S Takeda1, H Maeda, N Sawabata, S Kitada, M Mori, S Takashima, Y Matsubara.   

Abstract

BACKGROUND: Operative morbidity in patients with lung cancer associated with perioperative interstitial pneumonia (IP) has emerged as a serious problem. PATIENTS AND METHODS: We studied the clinical impact of perioperative related IP in 11 patients (IP group: 7 preoperative known, 4 acute onset) of 473 lung cancer patients who received a pulmonary resection. The IP group was compared to the remaining 462 patients (non-IP group). Demographic data, clinical presentation, and serum KL-6 levels were compared.
RESULTS: There were no differences in age, gender, type of surgery, and pulmonary function except for % DLco between the non-IP and IP groups. The IP group showed a higher in-hospital mortality (n=2: 18.3%) than that of the non-IP group (n=3: 0.6%) (P<0.005). Seven patients with underlying IP with high KL-6 levels showed an uneventful recovery. Two patients with postoperative onset of acute IP had a fatal course associated with elevation of serum KL-6 levels.
CONCLUSIONS: Postoperative development IP is a serious complication with high mortality, and serial measurement of KL-6 levels is useful to assess the activity of IP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16755450     DOI: 10.1055/s-2005-873068

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  3 in total

1.  Prediction of postoperative exacerbation of interstitial pneumonia in patients with lung cancer and interstitial lung disease.

Authors:  Akira Iyoda; Shi-Xu Jiang; Hideki Amano; Fumihiro Ogawa; Yoshio Matui; Naomi Kurouzu; Hidenori Hara; Kenji Nezu; Tetsuo Mikami; Makoto Saegusa; Yukitoshi Satoh
Journal:  Exp Ther Med       Date:  2011-08-24       Impact factor: 2.447

2.  Irradiation enhanced risks of hospitalised pneumonopathy in lung cancer patients: a population-based surgical cohort study.

Authors:  Shih-Kai Hung; Yi-Chun Chen; Wen-Yen Chiou; Chun-Liang Lai; Moon-Sing Lee; Yuan-Chen Lo; Liang-Cheng Chen; Li-Wen Huang; Nai-Chuan Chien; Szu-Chi Li; Dai-Wei Liu; Feng-Chun Hsu; Shiang-Jiun Tsai; Michael Wy Chan; Hon-Yi Lin
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

3.  Impact of interstitial lung disease on postoperative morbidity and 90-day mortality after pulmonary resection.

Authors:  Weipeng Shao; Jingjing Huang; Hongxiang Feng; Hongliang Sun; Yanhong Ren; Xiaowei Wang; Zhenrong Zhang; Deruo Liu
Journal:  Transl Cancer Res       Date:  2020-02       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.